CDR Information Session for the Pharmaceutical Industry
le 21 octobre 2005
Speakers’ Presentations
Introduction and welcome
Raymonde D’Amour, Facilitator
Evaluation of the Common Drug Review
Mike Tierney, Director, CDR
Proposed changes to the CDR Procedure
Elaine MacPhail, Program Advisor, CDR
Filing submissions – manufacturers’ comments on reviews
Sandra Pagotto, Manager, CDR Drug Reviews
Proposed changes to pharmacoeconomic requirements
Karen Lee, Health Economist, CDR